The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Manufacturers of medicines and biologicals are regularly inspected by us using a risk-based approach to ensure compliance with manufacturing principles.
We aim to resolve complaints informally wherever possible. However, more serious concerns should be made in writing to the Branch Head of our Manufacturing Quality Branch - see Contact us.
We recognise that the effective management of complaints and disputes contributes to improvements in regulatory services.